There are provided novel compounds of formula (I) wherein R
1
, R
2
and R
3
are as defined in the specification and pharmaceutically acceptable salts thereof; together with processes for their preparation, compositions containing them and their use in therapy. The compounds are inhibitors of the kinase Itk.